Back

Effect of PPAR-gamma agonist on exercise capacity in relation to body fat distribution in men with type 2 diabetes mellitus and coronary artery disease: a 1 year randomized study

11 April 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Moderated Posters Session 5 Secondary Prevention EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Doctor Marie-Eve Piche

Quebec Heart and Lung Institute, Quebec (Canada)

5 More presentations in this session

Presentation thumbnail
Does ethnicity play a role in acute myocardial infarction rate in hypertensive adult patients? A meta-analysis of randomized trial
Assistant Professor E. Cavarretta (Rome, IT)
Abstract
Presentation thumbnail
A cardio-metabolic score predicts long-term all-cause mortality after acute coronary syndrome
Doctor R. Pedretti (Milan, IT)
Abstract Slides
Presentation thumbnail
Moderate and heavy alcohol consumption are associated with decreased left ventricular ejection fraction after 8 years of follow-up: the Hoorn Study
Ms S. van Oort (Amsterdam, NL)
Abstract
Presentation thumbnail
Routinely measured 12h cardiac troponin T does not predict mortality in patients with ST elevation myocardial infarction
Doctor C. Bakogiannis (Thessaloniki, GR)
Abstract
Presentation thumbnail
Evaluation of exercise intolerance amongst patients with atrial fibrillation
Doctor A. Elliott (Adelaide, AU)

Access the full session

Session thumbnail
Moderated Posters Session 5

The Event

Event poster

EuroPrevent 2019

11 April - 13 April 2019
You may be interested in
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
thumbnail
Congress Presentation
Prevention should always follow intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources